{"id":60062,"date":"2024-09-24T10:04:13","date_gmt":"2024-09-24T08:04:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/"},"modified":"2024-09-24T10:04:13","modified_gmt":"2024-09-24T08:04:13","slug":"bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/","title":{"rendered":"Bio-Sourcing Secures European Innovation Council (EIC) Accelerator Funding to Bridge the Biomanufacturing Gap and Make Biotherapeutics More Available and Affordable"},"content":{"rendered":"
\n

\nThe funding \u2013 a \u20ac2.5M grant and additional \u20ac10M in equity – shows clear recognition of the ability of Bio-Sourcing\u2019s technical platform to impart changes on biomanufacturing sovereignty and to increase access to cutting-edge pharmaceuticals treatments, such as biosimilars<\/b>\n<\/p>\n

<\/a>
<\/a><\/p>\n

LI\u00c8GE, Belgium–(BUSINESS WIRE)–Bio-Sourcing, a pioneering Belgian biotherapeutic company, announces today the award of \u20ac2.5M in grants and \u20ac10M in equity from the European Innovation Council (EIC) Accelerator.\n<\/p>\n

\nThe funding will enable Bio-Sourcing to bring the first biosimilar adalimumab (Humira), a widely used treatment for autoimmune diseases to clinical trials by 2027. Adalimumab is expected to generate significant upfront payments and long-term royalties, which will be reinvested into further research and development. This will enable Bio-Sourcing to scale its operations and bring additional biosimilars to market.\n<\/p>\n

\n\u201cOur BioMilk platform is a game-changer for the biopharmaceutical industry,\u201d said Dr. Bertrand Merot, founder and CEO of Bio-Sourcing. \u201cThe recognition and financial support from the EIC Accelerator underscore the transformative potential of our platform and its importance in addressing global healthcare challenges. Not only are we advancing our mission to make biotherapeutics more affordable with this funding, we are also creating an opportunity for Europe to position itself as a leader in the global biopharmaceutical market.\u201d\n<\/p>\n

\nBio-Sourcing specializes in producing biotherapeutics, in particular monoclonal antibodies, in the milk of specialized goats. Bio-Sourcing\u2019s BioMilk platform leverages the natural ability of goats to produce complex proteins in their milk. This method is five times more cost-effective than traditional approaches and significantly reduces the environmental footprint of production.\n<\/p>\n

\nThe strategic significance of Bio-Sourcing\u2019s BioMilk platform extends beyond cost reduction. By enabling the domestic production of biosimilars, Bio-Sourcing sees an acute role in contributing to Europe\u2019s sovereignty in biopharmaceutical manufacturing. This is particularly important in light of recent global health crises, which have underscored the need for greater self-sufficiency in critical pharmaceutical supplies.\n<\/p>\n

\nBio-Sourcing will also expand the company premises, including the scaling-up of a goat facility and the building of an industrial milk processing plant.\n<\/p>\n

\nAbout Bio-Sourcing<\/b>\n<\/p>\n

\nBio-Sourcing is a biotechnology company that has developed a unique, sustainable and profitable platform for the production of a new generation of biotherapeutics, in particular monoclonal antibodies. Its technology platform is based on the production of biotherapeutics in goat\u2019s milk using genome editing and nuclear transfer technologies.
\n
www.bio-sourcing.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJuliette Schmitt
\n
juliette@ala.associates<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The funding \u2013 a \u20ac2.5M grant and additional \u20ac10M in equity – shows clear recognition of the ability of Bio-Sourcing\u2019s technical platform to impart changes on biomanufacturing sovereignty and to increase access to cutting-edge pharmaceuticals treatments, such as biosimilars LI\u00c8GE, Belgium–(BUSINESS WIRE)–Bio-Sourcing, a pioneering Belgian biotherapeutic company, announces today the award of \u20ac2.5M in grants … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60062","6":"format-standard","7":"category-industry"},"yoast_head":"\nBio-Sourcing Secures European Innovation Council (EIC) Accelerator Funding to Bridge the Biomanufacturing Gap and Make Biotherapeutics More Available and Affordable - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bio-Sourcing Secures European Innovation Council (EIC) Accelerator Funding to Bridge the Biomanufacturing Gap and Make Biotherapeutics More Available and Affordable - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The funding \u2013 a \u20ac2.5M grant and additional \u20ac10M in equity – shows clear recognition of the ability of Bio-Sourcing\u2019s technical platform to impart changes on biomanufacturing sovereignty and to increase access to cutting-edge pharmaceuticals treatments, such as biosimilars LI\u00c8GE, Belgium–(BUSINESS WIRE)–Bio-Sourcing, a pioneering Belgian biotherapeutic company, announces today the award of \u20ac2.5M in grants ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-24T08:04:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240924559520\/en\/2249164\/22\/logo_Bio-Sourcing_%281%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Bio-Sourcing Secures European Innovation Council (EIC) Accelerator Funding to Bridge the Biomanufacturing Gap and Make Biotherapeutics More Available and Affordable\",\"datePublished\":\"2024-09-24T08:04:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/\"},\"wordCount\":411,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240924559520\\\/en\\\/2249164\\\/22\\\/logo_Bio-Sourcing_%281%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/\",\"name\":\"Bio-Sourcing Secures European Innovation Council (EIC) Accelerator Funding to Bridge the Biomanufacturing Gap and Make Biotherapeutics More Available and Affordable - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240924559520\\\/en\\\/2249164\\\/22\\\/logo_Bio-Sourcing_%281%29.jpg\",\"datePublished\":\"2024-09-24T08:04:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240924559520\\\/en\\\/2249164\\\/22\\\/logo_Bio-Sourcing_%281%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240924559520\\\/en\\\/2249164\\\/22\\\/logo_Bio-Sourcing_%281%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bio-Sourcing Secures European Innovation Council (EIC) Accelerator Funding to Bridge the Biomanufacturing Gap and Make Biotherapeutics More Available and Affordable\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bio-Sourcing Secures European Innovation Council (EIC) Accelerator Funding to Bridge the Biomanufacturing Gap and Make Biotherapeutics More Available and Affordable - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/","og_locale":"en_US","og_type":"article","og_title":"Bio-Sourcing Secures European Innovation Council (EIC) Accelerator Funding to Bridge the Biomanufacturing Gap and Make Biotherapeutics More Available and Affordable - Pharma Trend","og_description":"The funding \u2013 a \u20ac2.5M grant and additional \u20ac10M in equity – shows clear recognition of the ability of Bio-Sourcing\u2019s technical platform to impart changes on biomanufacturing sovereignty and to increase access to cutting-edge pharmaceuticals treatments, such as biosimilars LI\u00c8GE, Belgium–(BUSINESS WIRE)–Bio-Sourcing, a pioneering Belgian biotherapeutic company, announces today the award of \u20ac2.5M in grants ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/","og_site_name":"Pharma Trend","article_published_time":"2024-09-24T08:04:13+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240924559520\/en\/2249164\/22\/logo_Bio-Sourcing_%281%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Bio-Sourcing Secures European Innovation Council (EIC) Accelerator Funding to Bridge the Biomanufacturing Gap and Make Biotherapeutics More Available and Affordable","datePublished":"2024-09-24T08:04:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/"},"wordCount":411,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240924559520\/en\/2249164\/22\/logo_Bio-Sourcing_%281%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/","url":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/","name":"Bio-Sourcing Secures European Innovation Council (EIC) Accelerator Funding to Bridge the Biomanufacturing Gap and Make Biotherapeutics More Available and Affordable - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240924559520\/en\/2249164\/22\/logo_Bio-Sourcing_%281%29.jpg","datePublished":"2024-09-24T08:04:13+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240924559520\/en\/2249164\/22\/logo_Bio-Sourcing_%281%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240924559520\/en\/2249164\/22\/logo_Bio-Sourcing_%281%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bio-sourcing-secures-european-innovation-council-eic-accelerator-funding-to-bridge-the-biomanufacturing-gap-and-make-biotherapeutics-more-available-and-affordable\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bio-Sourcing Secures European Innovation Council (EIC) Accelerator Funding to Bridge the Biomanufacturing Gap and Make Biotherapeutics More Available and Affordable"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60062"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60062\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}